Martin Maiers is the Vice President of Innovation at the NMDP/Be The Match

HLA’s future impact on allogeneic cell therapy development

Allogeneic cell therapies are inherently complex. But they also hold the potential to scale to treat large segments of the population. Martin Maiers, MS, is the Vice President of Innovation at the National Marrow Donor Program® (NMDP)/Be The Match®. He and his team develop software and analytical methods used to predict factors that can impact…